Reviewing the continued campaign by climate change skeptics, David McKnight, an associate professor at the University of New South Wales (Australia), notes that there several reasons why companies such as Exxon have had some success playing the global warming denial card. "First, the implications of the science are frightening.

Internal documents from the global drug company Eli Lilly reveal that it trained its sales force to avoid discussing the diabetes risk from Zyprexa, a drug used to treat schizophrenia and bipolar disorder.

If you're looking for "real reporting" these days, Glenn Greenwald thinks a lot of it is coming from whistleblowers and advocacy groups rather than from journalists.